28 studies found for:    "atypical hemolytic-uremic syndrome" OR "Hemolytic-Uremic Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"atypical hemolytic-uremic syndrome" OR "Hemolytic-Uremic Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Condition: Atypical Hemolytic-Uremic Syndrome
Intervention: Drug: Eculizumab
2 Completed
Has Results
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
Condition: Atypical Hemolytic-Uremic Syndrome
Intervention: Drug: Eculizumab
3 Recruiting Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry
Condition: Atypical Hemolytic-Uremic Syndrome
Intervention:
4 Recruiting Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease
Condition: Atypical Hemolytic Uraemic Syndrome.
Intervention:
5 Completed
Has Results
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: eculizumab
6 Completed A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
Intervention:
7 Enrolling by invitation aHUS Observational Long Term Follow-Up
Condition: Atypical Hemolytic Uremic Syndrome
Intervention:
8 Recruiting Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: eculizumab
9 Recruiting Complement Inhibition in aHUS Dialysis Patients
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: CCX168
10 Unknown  The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
Intervention: Drug: Eculizumab
11 Not yet recruiting The Role of Microparticles as a Biomarker
Conditions: Atypical Hemolytic Uremic Syndrome;   Thrombotic Thrombocytopenic Purpura;   Microparticles;   Microangiopathic Hemolytic Anemia
Intervention:
12 Completed
Has Results
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: Eculizumab
13 Completed
Has Results
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: Eculizumab
14 Completed
Has Results
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: eculizumab
15 Completed To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients
Condition: ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)
Intervention:
16 Completed Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4
Conditions: Hemolytic-uremic Syndrome;   Escherichia Coli Infections
Intervention: Other: HUS standard coverage care (including in ICU)
17 Enrolling by invitation Eval. of Potential Predictors of Disease Progression in Patients With aHUS Including Genetics, Biomarkers and Treatment
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Other: Clinical assessments and laboratory tests.
18 Completed Haemolytic Uraemic Syndrome in Childhood: Clinical, Cognitive and Psychological Aspects
Conditions: Hemolytic-Uremic Syndrome;   Children;   Parents;   Psychological Adjustment
Intervention:
19 Completed Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
Condition: Hemolytic Uremic Syndrome
Intervention: Drug: SYNSORB Pk
20 Unknown  Rituximab in Patients With Relapsed or Refractory TTP-HUS
Conditions: Thrombotic Thrombocytopenic Purpura;   Hemolytic Uremic Syndrome
Intervention: Drug: Rituximab

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years